Logo
Apparel & Fashion

Description

Arteether is a high-purity, semi-synthetic antimalarial Active Pharmaceutical Ingredient (API) derived from artemisinin. Supplied with an FDA-approved license from Maharashtra, this bulk API meets the rigorous standards of major international pharmacopeias, including IP, BP, EP, and USP. It is specifically engineered for its potent activity against Plasmodium falciparum malaria, including strains resistant to chloroquine. Available in ready stock, it provides pharmaceutical manufacturers with a reliable, compliant, and immediately accessible raw material essential for producing effective antimalarial medications, ensuring supply chain continuity for critical drug production.

This API is indispensable for the pharmaceutical industry, particularly for companies specializing in antimalarial drugs. Manufacturers of injectable formulations use it for severe malaria treatments, while producers of oral solid dosages incorporate it into tablets and combination therapies. It is a vital compone...
Arteether is a high-purity, semi-synthetic antimalarial Active Pharmaceutical Ingredient (API) derived from artemisinin. Supplied with an FDA-approved license from Maharashtra, this bulk API meets the rigorous standards of major international pharmacopeias, including IP, BP, EP, and USP. It is specifically engineered for its potent activity against Plasmodium falciparum malaria, including strains resistant to chloroquine. Available in ready stock, it provides pharmaceutical manufacturers with a reliable, compliant, and immediately accessible raw material essential for producing effective antimalarial medications, ensuring supply chain continuity for critical drug production.

This API is indispensable for the pharmaceutical industry, particularly for companies specializing in antimalarial drugs. Manufacturers of injectable formulations use it for severe malaria treatments, while producers of oral solid dosages incorporate it into tablets and combination therapies. It is a vital component for generic drug manufacturers, suppliers to government tenders, and organizations involved in global health initiatives aimed at malaria control and elimination in endemic regions, ensuring therapies remain effective against evolving resistant parasites.

Choosing this Arteether API delivers significant business value through assured reliability and regulatory simplicity. The ready stock availability minimizes production delays and inventory risks. The possession of an FDA-approved Maharashtra license streamlines the compliance process for both domestic and international buyers, facilitating smoother market entry. Consistent high purity and adherence to multiple pharmacopeial standards reduce manufacturing variability, leading to predictable yields, fewer quality rejections, and enhanced trust in the final drug product's safety and efficacy.

Key Features:
- Manufactured under an FDA-approved license from Maharashtra, ensuring regulatory compliance.
- Available in multiple pharmacopeia grades: IP, BP, EP, and USP specifications.
- Ready stock is maintained for immediate dispatch and supply chain reliability.
- High-purity API specifically effective against chloroquine-resistant malaria strains.
- Suitable for formulating both injectable and oral dosage forms.

Benefits:
- Enables uninterrupted manufacturing with readily available, in-stock API supply.
- Simplifies regulatory approval for drug manufacturers with pre-verified compliance.
- Offers formulation flexibility for injectable, tablet, and combination therapies.
- Provides consistent quality and purity, leading to reliable production outcomes.
- Supports global market access by meeting diverse international quality standards.

Specifications

Additional Information
Country of OriginIndia

Application

Arteether API is a potent semi-synthetic antimalarial agent specifically effective against chloroquine-resistant Plasmodium falciparum malaria. Pharmaceutical manufacturers rely on it to formulate critical medications that combat severe and drug-resistant malaria strains, particularly in regions where traditional treatments fail. Its high efficacy makes it a cornerstone ingredient for life-saving therapeutic interventions. This API is manufactured to meet stringent international pharmacopeia standards (IP, BP, EP, USP), ensuring compatibility with global regulatory frameworks. It is utilized in developing various dosage forms, from intramuscular injections for acute cases to oral tablets for treatment courses. Its stability and proven performance profile support consistent production for both commercial supply chains and essential public health initiatives. - Manufacturing intramuscular injectable solutions for the treatment of severe, complicated malaria. - Formulating oral solid dosage forms like tablets and capsules for complete antimalarial therapy. - Producing combination antimalarial drugs to enhance efficacy and combat parasite resistance. - Supplying active ingredient for pharmaceutical companies serving malaria-endemic regions worldwide. - Providing API for national and international public health programs and procurement agencies.

Trade Details

Available StockIn Stock
Sample AvailabilityNo

Payment Terms

Payment Terms
  • Custom Terms (manual entry)

Company Profile

A. S. Joshi & Company, Maharashtra
TruBasic
IndiaMaharashtra, India
Distributor / Wholesaler•Importer / Exporter
Factory Details
Factory SizeBelow 1000 sqm
Annual Production Capacity0

Arteether Bulk API Supplier FDA Approved Maharashtra License Ready Stock

Arteether Bulk API Supplier offers FDA-approved, Maharashtra-licensed antimalarial active pharmaceutical ingredient in IP, BP, EP, USP, and injectable grades for pharmaceutical manufacturing.

Min. Order Quantity: 1 unit

Shipping

Shipping fee and delivery date to be negotiated. Contact supplier now for more details.

A. S. Joshi & Company
TruBasic
IndiaMaharashtra, India
Distributor / Wholesaler

More Products From Supplier